Merck & Co., Inc: Alzheimer Disease trials
The registry lists 31 Alzheimer Disease studies with Merck & Co., Inc as lead sponsor. 1 are open to participants now and 20 have results posted.
Phase 1 18Phase 2 9Phase 3 4No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)RecruitingNCT07033494Phase 2
- Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)CompletedNCT06285240Phase 1Results posted
- Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)TerminatedNCT05602727Phase 2Results posted
- A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)CompletedNCT05466422Phase 1Results posted
- Elpipodect (MK-8189) Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017)CompletedNCT05227118Phase 1Results posted
- Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)CompletedNCT04730635Phase 1Results posted
- MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005)CompletedNCT04308304Phase 1Results posted
- An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)CompletedNCT02910739Phase 1Results posted
- Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061)CompletedNCT02750306Phase 3Results posted
- [11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)CompletedNCT02621606Phase 1Results posted
- [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)CompletedNCT02562989Phase 1Results posted
- Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)CompletedNCT02064920Phase 2Results posted
- Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)TerminatedNCT01953601Phase 3Results posted
- Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)TerminatedNCT01852110Phase 2Results posted
- An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)TerminatedNCT01739348Phase 2/3Results posted
- [18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002)TerminatedNCT01385033Phase 1Results posted
- Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001)CompletedNCT00954538Phase 1Results posted
- A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)TerminatedNCT00874939Phase 1Results posted
- A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)CompletedNCT00777608Phase 1Results posted
- A Study of V950 in People With Alzheimer Disease (V950-001 AM7)CompletedNCT00464334Phase 1Results posted
- MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)CompletedNCT00420420Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)TerminatedNCT06721156Phase 2
- A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003)CompletedNCT06586606Phase 1
- Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)WithdrawnNCT03740178Phase 1
- A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535])CompletedNCT01537757Phase 1
- A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1])CompletedNCT01496170Phase 1
- A Study to Evaluate the Use of an Indwelling Catheter to Obtain Cerebrospinal Fluid (CSF) by Low-rate Continuous Sampling (MK-0000-211)CompletedNCT01325662
- A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)CompletedNCT00757939Phase 1
- MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED)TerminatedNCT00362024Phase 2
- Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)CompletedNCT00074529Phase 2
- The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's DiseaseTerminatedNCT00006187Phase 3